Squarepoint
PDLI

Squarepoint’s PDL BioPharma, Inc. PDLI Stock Holding History

Squarepoint’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-40,402
Closed -$127K – 3465
2020
Q3 		$127K Sell
40,402
-30,220
-43% -$96.5K ﹤0.01% 2231
2020
Q2 		$206K Buy
+70,622
New +$223K ﹤0.01% 1816
2020
Q1 		– Sell
-113,986
Closed -$370K – 2856
2019
Q4 		$370K Sell
113,986
-150,636
-57% -$437K ﹤0.01% 1924
2019
Q3 		$572K Buy
264,622
+113,602
+75% +$304K 0.01% 1542
2019
Q2 		$474K Buy
151,020
+13,286
+10% +$43.1K ﹤0.01% 1701
2019
Q1 		$512K Buy
137,734
+84,539
+159% +$285K 0.01% 1474
2018
Q4 		$154K Sell
53,195
-32,348
-38% -$88.9K ﹤0.01% 1749
2018
Q3 		$225K Sell
85,543
-74,532
-47% -$183K ﹤0.01% 1706
2018
Q2 		$375K Buy
160,075
+45,375
+40% +$127K 0.01% 1288
2018
Q1 		$337K Buy
114,700
+82,954
+261% +$226K 0.01% 1269
2017
Q4 		$87K Buy
31,746
+8,532
+37% +$26.2K ﹤0.01% 1975
2017
Q3 		$79K Buy
+23,214
New +$64.5K ﹤0.01% 1529
2017
Q1 		– Sell
-111,390
Closed -$236K – 2206
2016
Q4 		$236K Buy
111,390
+90,590
+436% +$253K 0.01% 1312
2016
Q3 		$70K Buy
+20,800
New +$66K ﹤0.01% 969
2016
Q1 		– Sell
-49,000
Closed -$173K – 1690
2015
Q4 		$173K Buy
+49,000
New +$205K 0.02% 1036

Other funds holding PDLI

SPC
Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $688M AUM 63.39% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
HW
Hancock Whitney Gulfport, Mississippi $6B AUM 34.57% 1-Year Est. Return

Squarepoint's PDLI Position: Q4 2020 in Review

Squarepoint sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 40,402 shares — an estimated $127K sold.

Squarepoint first reported a position in PDLI in Q4 2015 and held it in 15 quarters. The position peaked at $572K in Q3 2019. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • Squarepoint reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • Squarepoint sold 40,402 PDL BioPharma, Inc. shares in Q4 2020, an estimated $127K.
  • Squarepoint first reported a position in PDL BioPharma, Inc. in Q4 2015 and held it in 15 quarters.
  • Squarepoint's PDL BioPharma, Inc. position peaked at $572K in Q3 2019.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on Squarepoint's 13F filing for Q4 2020, filed 16 Feb 2021.